Study on bladder cancer late effects and quality of life
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how long-term (late) effects after bladder cancer treatment affect quality of life. You may join if you recently had blood in your urine and are being evaluated for it in a specific region of Denmark.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were referred to a hospital in Denmark’s Central Region because of blood in your urine (hematuria) between 01/01/2022 and 01/01/2023.
- You can understand Danish well enough to complete written and spoken study questions.
- You do not have a known diagnosis of Alzheimer’s disease.
- No other diagnosed condition should explain your blood in urine (instead of bladder cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study from the University of Aarhus looks at ways to support sexual health in people who have been treated for bladder cancer. If you are a Danish-speaking adult who had bladder cancer treatment about a year ago and have noticed changes in sexual function, you may be able to join.
This study tracks patients with early-stage bladder cancer after surgery (TURBT) to see how often the cancer returns and how it affects your daily life.
This trial checks whether a new lab test on urine can help sort out which people with small amounts of blood in the urine (microscopic hematuria) might have bladder cancer. It may help doctors evaluate symptoms more accurately and decide who needs further testing.
This study follows people with urothelial cancer and certain rare genital (genitourinary) cancers over time to learn how these diseases progress. It may help researchers understand patterns of symptoms and outcomes, even if it is not a drug trial.
This study looks at how people with bladder cancer decide to join clinical trials. You may help researchers understand what matters most to patients like you.
This trial tests a new blood test that looks for signs bladder cancer may be coming back in people with a recent history of bladder cancer. It may help by making surveillance easier, but you must still follow a scheduled bladder-check plan.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.